CCOC(=O)CC(NS(=O)(=O)c1ccc2ncc(C(=O)O)c(O)c2c1)c1ccc(OCC)c(OC)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?